Italy’s Antitrust Authority cannot clear Intesa Sanpaolo’s offer for rival UBI for now because of uncertainties over a planned asset sale aimed at solving competition issues, a document showed on Tuesday, June 9.
In the document seen by Reuters which summarises the watchdog’s preliminary findings on the proposed takeover, the regulator stated it had not been able to take into consideration an accord between Intesa and BPER Banca.
Intesa has signed a binding agreement with BPER to sell 400-500 branches and €20 billion (US$22.68 billion) in assets as it seeks to take over UBI to create the Euro zone’s seventh-largest banking group.
“The (UBI) transaction can strengthen or create a dominant position for Intesa in numerous markets … reducing competition … in a significant and lasting way given the high market share and concentration, with a significant gap versus the second-biggest player in each area,” the document stated.
After the COVID-19 pandemic hit Italy, Intesa announced it was ready to accept a lower price from BPER to see the deal through.
The regulator stated it was not clear exactly which branches BPER would be buying and there were areas not affected by the deal which posed antitrust problems.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
T-Mobile’s Acquisition of Ka’ena Corporation Receives FCC Approval
Apr 26, 2024 by
CPI
UK Regulator Announces Two New Senior Executive Appointments
Apr 26, 2024 by
CPI
Paramount Global and Skydance Media Near Merger Deal, Eyeing CEO Change
Apr 26, 2024 by
CPI
BHP Unveils £31bn Mining Megamerger Proposal with Anglo American
Apr 25, 2024 by
nhoch@pymnts.com
ByteDance Prefers Shutdown Over Sale of TikTok Amid US Ban Threats
Apr 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI